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Primary leiomyosarcoma of the pulmonary artery: Is aggressive
treatment justified for a long survival?
Kalliopi Athanassiadi, MD,a Christina Grothusen, MS,b Michael Mengel, MD,c and Axel Haverich, MD,a
Hannover, Germany
Primary malignant tumors of the pulmonary artery (PA)are rare with a dismal prognosis despite diagnostic, op-erative, and oncologic advances.1 We report 2 cases ofprimary leiomyosarcoma of PA with a long survival of 7
and 2.5 years including clinical presentation, diagnosis, and sur-
gical treatment.
Material
Case 1. A 61-year-old woman was admitted to our department
with suspected chronic pulmonary thromboembolism resulting in a
complete occlusion of the right PA.2 The patient had chest pain
followed by a progressive limitation of physical fitness and dys-
pnea (New York Heart Association classes II and III). Computed
tomography (CT) scan revealed a hypodense formation with com-
plete occlusion of the right PA. A lung perfusion-scintigraphy
confirmed an almost complete loss of perfusion of the right lung,
and a cardiac catheterization showed a mild pulmonary hyperten-
sion. Preoperative biopsy revealed sarcoma. After staging with
cerebral magnetic resonance imaging and abdomen CT scan, the
patient underwent a median sternotomy to right pneumonectomy
and partial resection of the right main PA wall under cardiopul-
monary bypass and reconstruction with a pericardial patch. The
final histologic diagnosis stated leiomyosarcoma of low differen-
tiation (G3) of PA with invasion of the proximal PA resection area
(Figures 1 and 2). Subsequently, the patient underwent a second
operation under extracorporeal circulation with complete resection
of the PA trunk including the left PA. The reconstruction was
performed with a 6-cm polytetrafluoroethylene (Gore-Tex, Flag-
staff, Ariz) prosthesis. The postoperative recovery was uneventful.
In a follow-up of 7 years, she is alive with no recurrence. Her
quality of life and exercise tolerance have improved.
Case 2. A 65-year-old woman was admitted to our hospital
because of progressing dyspnea (New York Heart Association
classes III and IV) and chest pain. Her medical history was not
remarkable. Perfusion scintigraphy revealed absence of perfusion
of the left lung, and CT scan showed a lobulated mass in the left
PA outside the pericardium. No metastases were found, and the
patient underwent a left posterolateral thoracotomy to intrapericar-
dial pneumonectomy. The intraoperative diagnosis stated a pri-
mary leiomyosarcoma of low differentiation (G3) with free resec-
tion margins. The postoperative course was complicated with
respiratory insufficiency caused by pneumonia. Preventive radio-
therapy was suggested, but the patient refused. In a follow-up of
2.5 years she is still alive with no recurrence.
Discussion
Leiomyosarcomas of the PA are rare mesenchymal tumors with a
poor prognosis and a mean survival of 1.5 months if no treatment
is administered.1,2 Only 39 cases have been reported in the liter-
ature. Patients have a mean age of 50 years and show an equal
distribution of gender.3 Its intraluminal growth is usual, leading to
a progressive obstruction of right ventricular blood flow into the
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Figure 1. Cross section of pulmonary hilus with intraluminal
tumor growth.
Figure 2. Histologic section of PA.
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pulmonary circulation and a varying obstruction of pulmonary
perfusion, thus resulting in clinically unspecific symptoms of dys-
pnea, cough, or impaired right ventricular function mimicking
pulmonary thromboembolism in the majority of cases.2-4
The radiologic diagnosis can still be difficult despite the tech-
nologic advances in imaging techniques.1,5 Preoperative biopsy is
the only way to establish a proper diagnosis, and it is essential to
accurately plan the surgical approach.5
The only treatment of choice is radical surgical resection.4 De-
pending on tumor localization and distal extension, surgical treatment
includes PA resection, a polytetrafluoroethylene (Gore-Tex) ho-
mograft, or even xenograft reconstruction and pneumonectomy. The
use of cardiopulmonary bypass may be essential in patients in whom
the tumor originates from the PA trunk or the pulmonary valve. As
a palliative treatment, endovascular stent grafting may be an al-
ternative therapeutic option in inoperable cases. Furthermore, neo-
adjuvant or adjuvant chemotherapy has been mentioned in the
literature with doubtful results.
Prolonged tumor-free survival is rare. A 10-month survival is
reported in the literature for different sarcomas of PA,5 whereas in
our series survival was 7 and 2.5 years, respectively.
Conclusion
Early diagnosis along with aggressive and extensive surgical treat-
ment in patients with PA leiomyosarcoma without any extratho-
racic metastases may provide an opportunity for prolonged sur-
vival in addition to palliation.
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A new approach to the assessment of aortic cusp geometry
Hans-Joachim Schäfers, MD, PhD, Benjamin Bierbach, MD, and Diana Aicher, MD, Homburg/Saar, Germany
Repair of the aortic valve is a new surgical approach tothe treatment of aortic regurgitation. Regurgitation ofthe aortic valve can be caused by cusp distortion, rootdilatation, or a combination of both. For good func-
tional reconstruction, all pathologic components present have to be
addressed. Good results have been achieved with valve-preserving
aortic replacement,1 but isolated aortic valve reconstruction (ie,
cusp repair for prolapse) still remains a challenge to surgical
judgment.
The main problem in repair of aortic cusps is assessment of
pathology and the repair result. Root dilatation can easily be
quantified preoperatively by means of echocardiography or intra-
operative measurements. Cusp geometry, however, is difficult to
quantify by means of echocardiography. Measurements of cusp
dimensions are difficult to standardize intraoperatively, and these
dimensions determine cusp configuration only in conjunction with
sinus dimensions.2
The typical configuration of a normal aortic valve is not only
characterized by root dimensions but also the configuration of the
cusps. This includes a typical height difference between the central
free margins and the aortic insertion lines (Figure 1, A).3 We have
designed a caliper that allows easy and reproducible measurement
of this height difference, which we call effective height as opposed
to 2-dimensional cusp height.2 This measurement allows for iden-
tification of prolapse in the native cusps and assessment of pro-
lapse correction after valve repair.
Technical Description
After cardioplegia, stay sutures are placed in the aortic commis-
sures and kept under tension in the exact direction of the commis-
sures (as seen from the center of the root). The caliper is placed
such that the longer end rests on the lowest (ie, central) point of the
insertion line. The shorter end is pushed to the free margin, with
the curve accommodating the margin (Figure 1, B). The height
difference of the cusp (free edge to insertion) can be measured in
millimeters.
In normal aortic valves we have found effective height to range
from 8 to 10 millimeters, which correlated 1 mm with intraop-
erative transesophageal measurements. In approximately 50 repair
operations, we have found good correlation between effective
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